Find clinical trials for Lung Cancer in Indianapolis, IN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near Indianapolis, IN, USA:
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
combination) vs durvalumab in limited-stage (LS)-small-cell lung cancer (SCLC) participants.The main goals of this study are to:* E...
Phase 2
Indianapolis, Indiana, United States and 32 other locations
This study has 2 cohorts: MOZART-ES cohort (for extensive-stage SCLC) and MOZART-LS cohort (for limited-stage SCLC).MOZART-ES cohort: Study treatment...
Phase 2
Indianapolis, Indiana, United States and 3 other locations
combination, lurbinectedin with osimertinib, against a rare type of cancer known as transformed small cell lung cancer (SC...
Phase 1, Phase 2
Indianapolis, Indiana, United States
This phase II trial studies the effects of temozolomide and atezolizumab as second or third line treatment for patients with small cell lung ...
Phase 2
Indianapolis, Indiana, United States and 4 other locations
PUMA-ALI-4201 is a Phase 2 study evaluating alisertib monotherapy in patients with pathologically-confirmed small cell lung cancer ...
Phase 2
Indianapolis, Indiana, United States and 29 other locations
This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as...
Phase 3
Muncie, Indiana, United States and 182 other locations
of previously-untreated patients with extensive stage small cell lung cancer. Patients will receive initial chemo-immunotherapy fol...
Phase 2
Indianapolis, Indiana, United States and 4 other locations
The main objective is to compare the efficacy of tarlatamab with standard of care (SOC) on prolonging overall survival (OS).
Phase 3
Indianapolis, Indiana, United States and 224 other locations
following surgical resection in patients with stage I non-small cell lung cancer (NSCLC) with primary tumors between 1-4 c...
Phase 2
Indianapolis, Indiana, United States and 12 other locations
antibody in participants with advanced or metastatic non-small cell lung cancer (NSCLC). Cohort A will enroll participants who have...
Phase 1
Indianapolis, Indiana, United States and 4 other locations
Clinical trials
Research sites
Resources
Legal